提醒

CSL Limited (CSLLY)

OTC Markets OTCQX: CSLLY · 即時價格 · USD

31.00

-0.36 (-1.15%)

收盤價： Aug 27, 2026, 9:30 AM

股價、關鍵數字和最新消息，都在這一頁。

-1.15% (1D)

買價	30.93
市值	60.02B
營收 (ttm)	15.8B
淨利（ttm）	-2.58B
	0.09
	-1.34
	n/a
	18.86
P/B (ttm)	4.06
P/S (ttm)	3.80
財報日期	Feb 9, 2027

賣價	30.98
成交量	14,496
20 日平均成交量	368,844
開盤價	29.75
前收盤價	31.36
當日區間	29.75 - 31.00
52 週範圍	16.01 - 36.28
分析師	Hold
目標價	28.4 (-8.39%)
股利	$0.72 (2.34%)
除息日	2026年9月10日

關於 CSLLY

CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. The CSL Seqi...

[閱讀更多]

產業 Biotechnology

類股 Healthcare

IPO 日期 Dec 29, 2009

員工 29,000

證券交易所 OTC Markets OTCQX

股票代號 CSLLY

網站 https://www.csl.com

完整的公司簡介

財務表現

CSL 在 2026 年的營收為 15.7B，較前一年的 15.43B 增加 1.74%。淨利為 -2.58B，較前期減少 -185.91%。

財務報表

分析師預測

根據 1 位分析師的評等，CSLLY 的平均評等為「Hold」。12 個月目標價為 28.4，較最新價格有 8.39% 的下跌空間。

股票預測

下次財報發布

CSL Limited 的下次財報預計於 Feb 9, 2027, 盤中。
分析師預估營收 ... 升級

新聞動態

1 月前 · Investing.com

Australia to challenge Trump’s new 12.5% tariff, says PM Albanese

Investing.com -- Australian Prime Minister Anthony Albanese said he would raise Washington’s new 12.5% tariff on Australian goods directly with U.S. President Donald Trump, Reuters reported.

2 月前 · The Wall Street Journal

European Regulator Calls for Amgen’s Tavneos to Have Authorization Revoked

The committee is recommending that no new patients start treatment with Tavneos and that existing patients be switched to suitable alternatives.

3 月前 · Proactive

Imugene strengthens board with biotech and pharma appointments

Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has appointed Dr Charmaine Gittleson and Michael Kotsanis as non-executive directors as part of a board enhancement process aimed at supporting the company’s ...

3 月前 · Simply Wall St.

3 ASX Dividend Stocks Yielding Up To 4.2%

As the Australian market grapples with global uncertainties and fluctuating commodity prices, investors are increasingly seeking stability amidst the volatility. In such an environment, dividend stock...

3 月前 · GuruFocus.com

CSL Plunges 22% After Cutting Outlook And Flagging $5 Billion Impairments

CSL now expects weaker full-year revenue and profit as plasma, China pricing, and Vifor pressures weigh on performance.

第 1 頁，共 2 頁

CSL Limited (CSLLY)

關於 CSLLY

財務表現

分析師預測